Lonza
From cell therapy to scalable production
Lonza supports pharmaceutical and biotechnology companies in the development and production of innovative therapies. Its site in Geleen specialises in technology and production processes for cell and gene therapy. Lonza thus forms a vital link between groundbreaking biomedical research and reliable, large-scale application.
At the Brightlands Chemelot Campus, researchers are working on scaling up and reliably producing new therapies. The combination of specialist infrastructure and a strong life sciences network makes this an attractive location for professionals who want to bring medical innovation closer to the patient.
